Role of α2C‐adrenoceptor subtype in spatial working memory as revealed by mice with targeted disruption of the α2C‐adrenoceptor gene
- 1 February 1999
- journal article
- research article
- Published by Wiley in European Journal of Neuroscience
- Vol. 11 (2) , 599-603
- https://doi.org/10.1046/j.1460-9568.1999.00464.x
Abstract
The role of the α2C-adrenoceptor subtype in mediating the beneficial effect of α2-adrenoceptor agonists on spatial working memory was studied in adult mice with targeted inactivation of the α2C-receptor gene (KO) and their wild-type controls (WT). A delayed alternation task was run in a T-maze with mixed delays varying from 20 s to 120 s. Dexmedetomidine, a specific but subtype non-selective α2-adrenoceptor agonist, dose-dependently decreased the total number of errors. The effect was strongest at the dose of 5 μg/kg (s.c.), and was observed similarly in KO and WT mice. KO mice performed inferior to WT mice due to a higher number of perseverative errors. Dexmedetomidine slowed initiation of the motor response in the start phase at lower doses in WT mice than in KO mice but no such difference was observed in the return phase of the task, suggesting involvement of α2C-adrenoceptors in the cognitive aspect of response preparation or in response sequence initiation. According to these findings, enhancement of spatial working memory is best achieved with α2-adrenoceptor agonists which have neither agonistic nor antagonistic effects at the α2C-adrenoceptor subtype.Keywords
This publication has 21 references indexed in Scilit:
- The α -2a noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeysPsychopharmacology, 1998
- Medetomidine, atipamezole, and guanfacine in delayed response performance of aged monkeysPharmacology Biochemistry and Behavior, 1996
- Inactivation of Hippocampus or Caudate Nucleus with Lidocaine Differentially Affects Expression of Place and Response LearningNeurobiology of Learning and Memory, 1996
- Dopamine-dependent frontostriatal planning deficits in early Parkinson's disease.Neuropsychology, 1995
- Perikaryal and synaptic localization ofα2A-adrenergic receptor-like immunoreactivityBrain Research, 1994
- Coupling of human α2-adrenoceptor subtypes to regulation of cAMP production in transfected S115 cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Effects of medetomidine, an α-2 adrenoceptor agonist, and atipamezole, an α-2 antagonist, on spatial memory performance in adult and aged ratsBehavioral and Neural Biology, 1992
- Behavioral and receptor binding analysis of the α2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-YL amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an α2-adrenoceptor subtypeNeuropharmacology, 1991
- α 2 -Adrenergic Mechanisms in Prefrontal Cortex Associated with Cognitive Decline in Aged Nonhuman PrimatesScience, 1985
- Interaction between cholinergic and catecholaminergic agents in a spontaneous alternation taskPsychopharmacology, 1976